Association of the triglyceride-glucose index with all-cause and cardiovascular mortality in patients with cardiometabolic syndrome: a national cohort study
- PMID: 38402393
- PMCID: PMC10893675
- DOI: 10.1186/s12933-024-02152-y
Association of the triglyceride-glucose index with all-cause and cardiovascular mortality in patients with cardiometabolic syndrome: a national cohort study
Abstract
Objective: This study aimed to evaluate the association of triglyceride-glucose (TyG) index with all-cause and cardiovascular mortality risk among patients with cardiometabolic syndrome (CMS).
Methods: We performed a cohort study of 5754 individuals with CMS from the 2001-2018 National Health and Nutrition Examination Survey. The TyG index was calculated as Ln [fasting triglycerides (mg/dL) × fasting glucose (mg/dL)/2]. Multivariate Cox proportional hazards regression models assessed the associations between TyG index and mortality . Non-linear correlations and threshold effects were explored using restricted cubic splines and a two-piecewise Cox proportional hazards model.
Results: Over a median follow-up of 107 months, 1201 all-cause deaths occurred, including 398 cardiovascular disease-related deaths. The multivariate Cox proportional hazards regression model showed a positive association between the TyG index and all-cause and cardiovascular mortality. Each one-unit increase in the TyG index was associated with a 16% risk increase in all-cause mortality (HR: 1.16, 95% CI 1.03, 1.31, P = 0.017) and a 39% risk increase in cardiovascular mortality (HR: 1.39, 95% CI 1.14, 1.71, P = 0.001) after adjusting for confounders. The restricted cubic splines revealed a U-shaped association between the TyG index and all-cause (P for nonlinear < 0.001) and cardiovascular mortality (P for nonlinear = 0.044), identifying threshold values (all-cause mortality: 9.104; cardiovascular mortality: 8.758). A TyG index below these thresholds displayed a negative association with all-cause mortality (HR: 0.58, 95% CI 0.38, 0.90, P = 0.015) but not with cardiovascular mortality (HR: 0.39, 95% CI 0.12, 1.27, P = 0.119). Conversely, a TyG index exceeding these thresholds was positively associated with all-cause and cardiovascular mortality (HR: 1.35, 95% CI 1.17, 1.55, P < 0.001; HR: 1.54, 95% CI 1.25, 1.90, P < 0.001, respectively). Notably, a higher TyG index (≥ threshold values) was significantly associated with increased mortality only among individuals aged under 55 compared to those with a lower TyG index (< threshold values).
Conclusions: The TyG index demonstrated a U-shaped correlation with all-cause and cardiovascular mortality in individuals with CMS. The thresholds of 9.104 and 8.758 for all-cause and cardiovascular mortality, respectively, may be used as intervention targets to reduce the risk of premature death and cardiovascular disease.
Keywords: Cardiometabolic syndrome; Insulin resistance; Mortality; NHANES; Triglyceride-glucose index.
© 2024. The Author(s).
Conflict of interest statement
The authors declare no competing interests that pertain to this work.
Figures



Similar articles
-
The triglyceride-glucose index is a predictor for cardiovascular and all-cause mortality in CVD patients with diabetes or pre-diabetes: evidence from NHANES 2001-2018.Cardiovasc Diabetol. 2023 Oct 17;22(1):279. doi: 10.1186/s12933-023-02030-z. Cardiovasc Diabetol. 2023. PMID: 37848879 Free PMC article.
-
Association of the triglyceride-glucose index with all-cause and cardiovascular mortality among individuals with cardiovascular-kidney-metabolic syndrome: a population-based cohort study using data from the US National Health and Nutrition Examination Survey, 1999-2018.BMJ Open. 2025 May 21;15(5):e093383. doi: 10.1136/bmjopen-2024-093383. BMJ Open. 2025. PMID: 40398946 Free PMC article.
-
Association of triglyceride glucose index with all-cause and cardiovascular mortality in the general population.Cardiovasc Diabetol. 2023 Nov 22;22(1):320. doi: 10.1186/s12933-023-02054-5. Cardiovasc Diabetol. 2023. PMID: 37993902 Free PMC article.
-
Association between triglyceride-glucose related indices and all-cause and cardiovascular mortality among the population with cardiovascular-kidney-metabolic syndrome stage 0-3: a cohort study.Cardiovasc Diabetol. 2025 Feb 28;24(1):92. doi: 10.1186/s12933-025-02642-7. Cardiovasc Diabetol. 2025. PMID: 40022225 Free PMC article.
-
Triglyceride-Glucose Index As A Biomarker Of Insulin Resistance, Diabetes Mellitus, Metabolic Syndrome, And Cardiovascular Disease: A Review.EJIFCC. 2024 Apr 11;35(1):44-51. eCollection 2024 Apr. EJIFCC. 2024. PMID: 38706737 Free PMC article. Review.
Cited by
-
The triglyceride-glucose index is a predictor of major adverse cardiovascular events in patients with coronary artery disease and psoriasis: a retrospective cohort study.Diabetol Metab Syndr. 2024 Jul 31;16(1):184. doi: 10.1186/s13098-024-01423-8. Diabetol Metab Syndr. 2024. PMID: 39085887 Free PMC article.
-
Emergency risk stratification using the TyG index: a multi-center cohort study on nonlinear association with 28-day mortality among critically ill patients transferred from the ED to the ICU.Front Med (Lausanne). 2025 Jul 30;12:1605843. doi: 10.3389/fmed.2025.1605843. eCollection 2025. Front Med (Lausanne). 2025. PMID: 40809413 Free PMC article.
-
Evaluative performance of TyG-ABSI versus traditional indices in relation to cardiovascular disease and mortality: evidence from the U.S. NHANES.Cardiovasc Diabetol. 2025 Aug 21;24(1):344. doi: 10.1186/s12933-025-02902-6. Cardiovasc Diabetol. 2025. PMID: 40841630 Free PMC article.
-
The impact of the triglyceride-glucose index on the deterioration of kidney function in patients with cardiovascular-kidney-metabolic syndrome: insight from a large cohort study in China.Ren Fail. 2025 Dec;47(1):2446656. doi: 10.1080/0886022X.2024.2446656. Epub 2025 Jan 5. Ren Fail. 2025. PMID: 39757592 Free PMC article.
-
Sex-specific association between triglyceride-glucose index and all-cause mortality in patients with osteoporotic fractures: a retrospective cohort study.Front Endocrinol (Lausanne). 2025 Apr 30;16:1574238. doi: 10.3389/fendo.2025.1574238. eCollection 2025. Front Endocrinol (Lausanne). 2025. PMID: 40370776 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical